ArticleCancer control : journal of the Moffitt Cancer Center

Adverse Events of Immune Checkpoint Inhibitors in Cancer Patients with Comorbid Diabetes: A Real-World Pharmacovigilance Analysis of the FDA Adverse Event Reporting System Database (2011-2025).

Minxia Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.